Daiichi Sankyo

Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Mon, 08/7/23 - 10:14 am
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
Enhertu offers survival benefits in Phase II solid tumour trial
Clinical Trials Arena
Sat, 07/29/23 - 10:42 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
solid tumors
FDA okays Daiichi Sankyo’s Vanflyta for first-line AML
Pharmaphorum
Fri, 07/21/23 - 10:08 am
Daiichi Sankyo
Vanflyta
FDA
AML
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
EP Vantage
Wed, 06/7/23 - 10:02 am
ASCO 2023
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
non-small cell lung cancer
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
BioPharma Dive
Thu, 05/25/23 - 08:51 pm
ASCO 2023
antibody-drug conjugate
Merck
BioNTech
Daiichi Sankyo
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
FDA again delays Daiichi's plans to challenge Astellas and Novartis for blood cancer market
Fierce Biotech
Fri, 04/21/23 - 10:08 am
Daiichi Sankyo
Astellas
Novartis
quizartinib
FDA
blood cancer
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit
Fierce Pharma
Tue, 03/28/23 - 10:57 pm
Esperion Therapeutics
Daiichi Sankyo
Nexletol
SEC
Zymeworks, Daiichi end $293M bispecific collab after 6 unfruitful years
Fierce Biotech
Mon, 03/20/23 - 09:56 am
Zymeworks
Daiichi Sankyo
immuno-oncology
biobucks
Daiichi torches Esperion’s Nexletol milestone promises
EP Vantage
Fri, 03/17/23 - 10:10 am
Daiichi Sankyo
Esperion Therapeutics
Nexletol
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
Mon, 03/6/23 - 11:27 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
Daiichi Sankyo gets US patent office to restart review of Seagen patent
Endpoints
Mon, 02/20/23 - 12:40 pm
Daiichi Sankyo
Seagen
PTO
patents
Daiichi Sankyo to build Japan's first mRNA vaccine manufacturing facility — report
Endpoints
Wed, 02/8/23 - 10:58 pm
Daiichi Sankyo
Japan
MRNA
vaccines
drug manufacturing
The first big test for the son of Enhertu
EP Vantage
Fri, 01/20/23 - 10:17 am
Daiichi Sankyo
Enhertu
datopotamab deruxtecan
clinical trials
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
pharma stocks
Merck
Eli Lilly
AbbVie
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Sarepta Therapeutics
Halozyme
Horizon Therapeutics
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte

Pages